Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation

We have investigated the pathological correlates of dementia in the brains from a consecutive series of 70 patients dying with a clinical diagnosis of frontotemporal lobar degeneration (FTLD). Clinical misdiagnosis rate was low with only 3 patients (4%) failing to show pathological changes consistent with this diagnosis; 1 patient had Alzheimer’s disease and 2 had cerebrovascular disease (CVD). In the remaining 67 patients, the most common underlying histological cause was ubiquitin pathology with 24 (36%) cases so affected. In these, ubiquitin-positive inclusions were present in the cerebral cortex as small, rounded or crescent-shaped structures within the cytoplasm of neurones of layer II, together with coiled or curvilinear bodies within neurites, and in the hippocampus as small, solid and more spherical-shaped inclusion bodies within the cytoplasm of dentate gyrus granule cells. In one patient, “cat’s eye” or “lentiform” intranuclear ubiquitin inclusions were also present. The second most common histological type was dementia lacking distinctive histology (DLDH), in which neither tau nor ubiquitin inclusions were present, with 16 cases (24%) being affected. Pick-type histology was seen in 14 cases (21%) and tau histological changes associated with frontotemporal dementia (FTD) linked to chromosome 17 (FTDP-17) were present in 11 cases (16%). One case (1%) showed an unusual tau pathology that could not be allocated to any of the other tau groups. Only 1 case (1%) had neuronal intermediate filament inclusion dementia. No cases with ubiquitinated, valosin-containing protein-immunoreactive intranuclear inclusion bodies of the type seen in inclusion body myopathy with Paget’s disease of bone and frontotemporal dementia were seen. Clinicopathological correlation showed that any of these histological subtypes can be associated with FTD. However, for FTD with motor neurone disease (FTD+MND), semantic dementia or primary progressive aphasia (PA), the histological profile was either ubiquitin type or DLDH type; Pick-type histology was seen in only 1 case of PA. None of these latter three clinical subtypes was associated with a mutation in tau gene and FTDP-17 type of tau pathology. All cases of progressive apraxia were associated with Pick-type histology. Present data therefore indicate that, although ubiquitin pathology is the most common histological form associated with FTLD, this pathology is not tightly linked with, nor is pathologically diagnostic for, any particular clinical form of the disease, including FTD+MND.

[1]  J. Trojanowski,et al.  alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. , 2004, The American journal of pathology.

[2]  D. Dickson,et al.  Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS , 2003, Neuropathology and applied neurobiology.

[3]  M N Rossor,et al.  Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. , 2000, Brain : a journal of neurology.

[4]  J. Hodges,et al.  Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.

[5]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[6]  Andrew Kertesz,et al.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.

[7]  J. Trojanowski,et al.  Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. , 2005, Journal of neuropathology and experimental neurology.

[8]  P. Pástor,et al.  Multiple cervical artery dissections , 2005, Neurology.

[9]  J. Trojanowski,et al.  Update on the Neuropathological Diagnosis of Frontotemporal Dementias , 2001, Journal of neuropathology and experimental neurology.

[10]  M. Bergmann,et al.  Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study , 1996, Acta Neuropathologica.

[11]  J. Trojanowski,et al.  Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[12]  L. Forno,et al.  Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type , 2002, Acta Neuropathologica.

[13]  H. Feldman,et al.  The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease , 2003, Acta Neuropathologica.

[14]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[15]  C. Bouras,et al.  Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study , 2004, Acta Neuropathologica.

[16]  M. W. Wooten,et al.  Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation , 2005, Journal of neurochemistry.

[17]  Standardizing frontotemporal dementia: the problem of polysemy. , 2002, Archives of neurology.

[18]  Nick C Fox,et al.  Neurofilament inclusion body disease: a new proteinopathy? , 2003, Brain : a journal of neurology.

[19]  Philip Scheltens,et al.  Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. , 2003, Brain : a journal of neurology.

[20]  G. Leuba,et al.  Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21–22 , 2003, Neurobiology of Disease.

[21]  J. Lowe,et al.  Motor neurone disease-inclusion dementia. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[22]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[23]  W. Kamphorst,et al.  Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.

[24]  J. Strominger,et al.  p62, a Phosphotyrosine-independent Ligand of the SH2 Domain of p56lck, Belongs to a New Class of Ubiquitin-binding Proteins* , 1996, The Journal of Biological Chemistry.

[25]  L. Lannfelt,et al.  Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP‐17 family , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[26]  H. Doshi,et al.  Pick's disease , 1991, Neurology.

[27]  Julie S. Snowden,et al.  Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia , 1996 .

[28]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[29]  Ian G. McKeith,et al.  Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions , 2003, Neuroscience Letters.

[30]  T D Bird,et al.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions , 2000, Neurology.

[31]  D. Mann,et al.  The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein , 2004, Neuropathology and applied neurobiology.

[32]  H. Akiyama,et al.  Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62 , 2003, Neuroscience Letters.

[33]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[34]  M N Rossor,et al.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry , 2004, Neuropathology and applied neurobiology.

[35]  G. Leuba,et al.  Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease , 2000, Acta Neuropathologica.

[36]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[37]  E. Bigio,et al.  Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration , 2004, Acta Neuropathologica.

[38]  A. Probst,et al.  Frontal lobe degeneration: novel ubiquitin‐immunoreactive neurites within frontotemporal cortex , 1995, Neuropathology and applied neurobiology.

[39]  J. Haines,et al.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. , 2000, JAMA.

[40]  L. Hocking,et al.  Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. , 2002, Human molecular genetics.

[41]  C. Duijn,et al.  Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.

[42]  S. Hirai,et al.  Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease , 1992, Journal of Neurology.

[43]  M. Swash,et al.  Ubiquitin deposits in anterior horn cells in motor neurone disease , 1988, Neuroscience Letters.

[44]  M. Mesulam,et al.  Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[45]  D. Neary,et al.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.

[46]  H. Kaiya,et al.  Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. , 1987, Archives of gerontology and geriatrics.

[47]  J. Hardy,et al.  Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. , 2002, Brain : a journal of neurology.

[48]  Jacques P. Brown,et al.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.

[49]  K. Kosaka,et al.  Ubiquitin and ubiquitin‐related proteins in the brains of patients with atypical Pick's disease without Pick bodies and dementia with motor neuron disease , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.

[50]  A. Meyer Über eine der amyotrophischen Lateralsklerose nahestehende Erkrankung mit psychischen Störungen , 1929 .

[51]  R. Mayer,et al.  A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin , 1988, Neuroscience Letters.

[52]  E. Kuusisto,et al.  Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation , 2002, Neuropathology and applied neurobiology.

[53]  D. Neary,et al.  Frontal lobe dementia and motor neuron disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[54]  G. Leuba,et al.  Search for a Mutation in the tau Gene in a Swiss Family with Frontotemporal Dementia , 2000, Experimental Neurology.

[55]  E. Kuusisto,et al.  Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies , 2001, Neuroreport.

[56]  L. Lannfelt,et al.  No evidence of linkage to chromosome 9q21–22 in a Swedish family with frontotemporal dementia and amyotrophic lateral sclerosis , 2003, Neuroscience Letters.

[57]  K. Nakashima,et al.  Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum , 2004, Acta Neuropathologica.